Vyne Therapeutics Correlations

VYNE Stock

USD 0.94 0.02 2.17%

The correlation of Vyne Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Vyne Therapeutics Correlation With Market

Weak diversification

The correlation between Vyne Therapeutics and DJI is 0.3 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Vyne Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Vyne Stock

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vyne Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For information on how to trade Vyne Stock refer to our How to Trade Vyne Stock guide.

Moving together with Vyne Stock

0.66	EQ	Equillium	Pair Corr
0.77	VALN	Valneva SE ADR	Pair Corr
0.86	VCYT	Veracyte	Pair Corr
0.81	DRRX	Durect	Pair Corr
0.76	DRUG	Bright Minds Biosciences	Pair Corr
0.8	CDIOW	Cardio Diagnostics	Pair Corr
0.7	DVAX	Dynavax Technologies	Pair Corr
0.89	DYAI	Dyadic International	Pair Corr
0.78	VRTX	Vertex Pharmaceuticals	Pair Corr

Moving against Vyne Stock

0.85	VIGL	Vigil Neuroscience	Pair Corr
0.82	DRTS	Alpha Tau Medical	Pair Corr
0.68	KG	KING PHARMACEUTICALS INC Symbol Change	Pair Corr
0.6	VANI	Vivani Medical	Pair Corr
0.85	ELAN	Elanco Animal Health	Pair Corr
0.83	VRNA	Verona Pharma PLC	Pair Corr
0.78	VTYX	Ventyx Biosciences Buyout Trend	Pair Corr
0.75	EDIT	Editas Medicine Buyout Trend	Pair Corr
0.48	VRCA	Verrica Pharmaceuticals	Pair Corr
0.39	VTRS	Viatris	Pair Corr
0.35	VXRT	Vaxart Inc	Pair Corr
0.31	VKTX	Viking Therapeutics	Pair Corr

Related Correlations Analysis

	AKTX	SLRX	AXLA	MGTA	HSTO	FWBI	SABS	VCNX	GOVX	CBIO
AKTX		0.24	0.0	0.0	-0.16	0.0	0.44	0.0	0.03	0.0	AKTX
SLRX	0.24		0.0	0.0	0.29	0.0	0.33	0.0	0.38	0.0	SLRX
AXLA	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	AXLA
MGTA	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	MGTA
HSTO	-0.16	0.29	0.0	0.0		0.0	-0.55	0.0	0.64	0.0	HSTO
FWBI	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	FWBI
SABS	0.44	0.33	0.0	0.0	-0.55	0.0		0.0	0.07	0.0	SABS
VCNX	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	VCNX
GOVX	0.03	0.38	0.0	0.0	0.64	0.0	0.07	0.0		0.0	GOVX
CBIO	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		CBIO
	AKTX	SLRX	AXLA	MGTA	HSTO	FWBI	SABS	VCNX	GOVX	CBIO

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

GOVX	+ 0.64	HSTO
SABS	+ 0.44	AKTX
GOVX	+ 0.38	SLRX
SABS	+ 0.33	SLRX
HSTO	+ 0.29	SLRX
SLRX	+ 0.24	AKTX

High negative correlations

SABS	- 0.55	HSTO
HSTO	- 0.16	AKTX
CBIO	- 0.0	GOVX
CBIO	- 0.0	VCNX
GOVX	- 0.0	VCNX
CBIO	- 0.0	SABS

Risk-Adjusted Indicators

There is a big difference between Vyne Stock performing well and Vyne Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Vyne Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
AKTX	4.50	0.22	0.04	1.36	4.73	(5.35)	10.00	(8.33)	31.29
SLRX	5.10	0.68	0.09	(0.60)	5.89	(6.91)	9.86	(7.04)	38.43
AXLA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MGTA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HSTO	5.31	(1.41)	0.00	4.95	0.00	0.00	10.80	(10.71)	93.31
FWBI	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SABS	4.19	0.26	0.05	0.25	4.63	(4.74)	10.43	(7.26)	23.93
VCNX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
GOVX	5.43	(0.45)	0.00	(0.19)	0.00	0.00	8.79	(9.65)	59.97
CBIO	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Vyne Therapeutics Corporate Management

Russell DPhil	VP Devel	Profile
Iain Stuart	Chief Officer	Profile
MS MD	Consultant	Profile
Subhashis MD	Senior Development	Profile
David Schuz	VP Property	Profile
Faad MD	Consultant	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC